Location History:
- Xiamen, CN (2021 - 2022)
- Fujian, CN (2023)
Company Filing History:
3 out of 153 
3 out of 23 Years Active: 2021-2023
Title: Maozhou He: Innovator in HPV Vaccine Development
Introduction
Maozhou He is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines targeting human papillomavirus (HPV). With a total of three patents to his name, his work focuses on innovative solutions to combat HPV-related diseases.
Latest Patents
Maozhou He's latest patents include a mutant of the L1 protein of human papillomavirus type 18. This invention relates to a mutated HPV18 L1 protein, a sequence encoding the same, and a virus-like particle that can induce the generation of neutralizing antibodies against at least two HPV types, such as HPV18 and HPV45. This innovation has potential applications in preventing infections and diseases caused by these HPV types, including cervical cancer and condyloma acuminatum.
Another significant patent involves a mutant of the L1 protein of human papillomavirus type 16. This invention provides a mutated HPV16 L1 protein and a virus-like particle capable of inducing neutralizing antibodies against at least two types of HPV, including HPV16 and HPV35. Similar to his other patent, this invention can be utilized in the manufacture of pharmaceutical compositions or vaccines aimed at preventing infections and related diseases.
Career Highlights
Maozhou He has worked at notable institutions, including Xiamen University and Xiamen Innovax Biotech Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in HPV vaccine development.
Collaborations
Some of his notable coworkers include Shaowei Li and Shuo Song. Their collaborative efforts have further advanced the research and development of innovative solutions in the biotechnology sector.
Conclusion
Maozhou He is a key figure in the fight against HPV-related diseases through his innovative patents and contributions to vaccine development. His work continues to have a significant impact on public health and the advancement of biotechnology.